TY  - GEN
AU  - Diener,H C
AU  - Dodick,D W
AU  - Aurora,S K
AU  - Turkel,C C
AU  - DeGryse,R E
AU  - Lipton,R B
AU  - Silberstein,S D
AU  - Brin,M F
TI  - OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
SN  - 1468-2982
PY  - 2010///1116
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Botulinum Toxins, Type A
KW  - therapeutic use
KW  - Chronic Disease
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Migraine Disorders
KW  - drug therapy
KW  - Neuromuscular Agents
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1177/0333102410364677
ER  -